Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Both treatments improved hair quality and thickness equally, with mild side effects.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

PRP treatment helps 70.1% of hair loss patients after two sessions.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

CS12192 effectively treats alopecia areata with better safety than current options.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.